Leiomyosarcoma Drug
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Premature Labor Treatment Market Research Report 2024
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Premature Labor Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Progesterone
1.2.3 OBE-022
1.2.4 Retosiban
1.2.5 Others
1.3 Market by Application
1.3.1 Global Premature Labor Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Premature Labor Treatment Market Perspective (2017-2028)
2.2 Premature Labor Treatment Growth Trends by Region
2.2.1 Premature Labor Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Premature Labor Treatment Historic Market Size by Region (2017-2022)
2.2.3 Premature Labor Treatment Forecasted Market Size by Region (2023-2028)
2.3 Premature Labor Treatment Market Dynamics
2.3.1 Premature Labor Treatment Industry Trends
2.3.2 Premature Labor Treatment Market Drivers
2.3.3 Premature Labor Treatment Market Challenges
2.3.4 Premature Labor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Premature Labor Treatment Players by Revenue
3.1.1 Global Top Premature Labor Treatment Players by Revenue (2017-2022)
3.1.2 Global Premature Labor Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Premature Labor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Premature Labor Treatment Revenue
3.4 Global Premature Labor Treatment Market Concentration Ratio
3.4.1 Global Premature Labor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premature Labor Treatment Revenue in 2021
3.5 Premature Labor Treatment Key Players Head office and Area Served
3.6 Key Players Premature Labor Treatment Product Solution and Service
3.7 Date of Enter into Premature Labor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Premature Labor Treatment Breakdown Data by Type
4.1 Global Premature Labor Treatment Historic Market Size by Type (2017-2022)
4.2 Global Premature Labor Treatment Forecasted Market Size by Type (2023-2028)
5 Premature Labor Treatment Breakdown Data by Application
5.1 Global Premature Labor Treatment Historic Market Size by Application (2017-2022)
5.2 Global Premature Labor Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Premature Labor Treatment Market Size (2017-2028)
6.2 North America Premature Labor Treatment Market Size by Country (2017-2022)
6.3 North America Premature Labor Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Premature Labor Treatment Market Size (2017-2028)
7.2 Europe Premature Labor Treatment Market Size by Country (2017-2022)
7.3 Europe Premature Labor Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Premature Labor Treatment Market Size (2017-2028)
8.2 Asia-Pacific Premature Labor Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Premature Labor Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Premature Labor Treatment Market Size (2017-2028)
9.2 Latin America Premature Labor Treatment Market Size by Country (2017-2022)
9.3 Latin America Premature Labor Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Premature Labor Treatment Market Size (2017-2028)
10.2 Middle East & Africa Premature Labor Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Premature Labor Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AMAG Pharmaceuticals Inc
11.1.1 AMAG Pharmaceuticals Inc Company Detail
11.1.2 AMAG Pharmaceuticals Inc Business Overview
11.1.3 AMAG Pharmaceuticals Inc Premature Labor Treatment Introduction
11.1.4 AMAG Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2017-2022)
11.1.5 AMAG Pharmaceuticals Inc Recent Development
11.2 GlaxoSmithKline Plc
11.2.1 GlaxoSmithKline Plc Company Detail
11.2.2 GlaxoSmithKline Plc Business Overview
11.2.3 GlaxoSmithKline Plc Premature Labor Treatment Introduction
11.2.4 GlaxoSmithKline Plc Revenue in Premature Labor Treatment Business (2017-2022)
11.2.5 GlaxoSmithKline Plc Recent Development
11.3 Juniper Pharmaceuticals Inc
11.3.1 Juniper Pharmaceuticals Inc Company Detail
11.3.2 Juniper Pharmaceuticals Inc Business Overview
11.3.3 Juniper Pharmaceuticals Inc Premature Labor Treatment Introduction
11.3.4 Juniper Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2017-2022)
11.3.5 Juniper Pharmaceuticals Inc Recent Development
11.4 Kissei Pharmaceutical Co Ltd
11.4.1 Kissei Pharmaceutical Co Ltd Company Detail
11.4.2 Kissei Pharmaceutical Co Ltd Business Overview
11.4.3 Kissei Pharmaceutical Co Ltd Premature Labor Treatment Introduction
11.4.4 Kissei Pharmaceutical Co Ltd Revenue in Premature Labor Treatment Business (2017-2022)
11.4.5 Kissei Pharmaceutical Co Ltd Recent Development
11.5 Lipocine Inc
11.5.1 Lipocine Inc Company Detail
11.5.2 Lipocine Inc Business Overview
11.5.3 Lipocine Inc Premature Labor Treatment Introduction
11.5.4 Lipocine Inc Revenue in Premature Labor Treatment Business (2017-2022)
11.5.5 Lipocine Inc Recent Development
11.6 ObsEva SA
11.6.1 ObsEva SA Company Detail
11.6.2 ObsEva SA Business Overview
11.6.3 ObsEva SA Premature Labor Treatment Introduction
11.6.4 ObsEva SA Revenue in Premature Labor Treatment Business (2017-2022)
11.6.5 ObsEva SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Premature Labor Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Progesterone
Table 3. Key Players of OBE-022
Table 4. Key Players of Retosiban
Table 5. Key Players of Others
Table 6. Global Premature Labor Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Premature Labor Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Premature Labor Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Premature Labor Treatment Market Share by Region (2017-2022)
Table 10. Global Premature Labor Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Premature Labor Treatment Market Share by Region (2023-2028)
Table 12. Premature Labor Treatment Market Trends
Table 13. Premature Labor Treatment Market Drivers
Table 14. Premature Labor Treatment Market Challenges
Table 15. Premature Labor Treatment Market Restraints
Table 16. Global Premature Labor Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Premature Labor Treatment Market Share by Players (2017-2022)
Table 18. Global Top Premature Labor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Labor Treatment as of 2021)
Table 19. Ranking of Global Top Premature Labor Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Premature Labor Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Premature Labor Treatment Product Solution and Service
Table 23. Date of Enter into Premature Labor Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Premature Labor Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Premature Labor Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Premature Labor Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Premature Labor Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Premature Labor Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Premature Labor Treatment Revenue Market Share by Application (2017-2022)
Table 31. Global Premature Labor Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Premature Labor Treatment Revenue Market Share by Application (2023-2028)
Table 33. North America Premature Labor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Premature Labor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Premature Labor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Premature Labor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Premature Labor Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Premature Labor Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Premature Labor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Premature Labor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Premature Labor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Premature Labor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. AMAG Pharmaceuticals Inc Company Detail
Table 44. AMAG Pharmaceuticals Inc Business Overview
Table 45. AMAG Pharmaceuticals Inc Premature Labor Treatment Product
Table 46. AMAG Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2017-2022) & (US$ Million)
Table 47. AMAG Pharmaceuticals Inc Recent Development
Table 48. GlaxoSmithKline Plc Company Detail
Table 49. GlaxoSmithKline Plc Business Overview
Table 50. GlaxoSmithKline Plc Premature Labor Treatment Product
Table 51. GlaxoSmithKline Plc Revenue in Premature Labor Treatment Business (2017-2022) & (US$ Million)
Table 52. GlaxoSmithKline Plc Recent Development
Table 53. Juniper Pharmaceuticals Inc Company Detail
Table 54. Juniper Pharmaceuticals Inc Business Overview
Table 55. Juniper Pharmaceuticals Inc Premature Labor Treatment Product
Table 56. Juniper Pharmaceuticals Inc Revenue in Premature Labor Treatment Business (2017-2022) & (US$ Million)
Table 57. Juniper Pharmaceuticals Inc Recent Development
Table 58. Kissei Pharmaceutical Co Ltd Company Detail
Table 59. Kissei Pharmaceutical Co Ltd Business Overview
Table 60. Kissei Pharmaceutical Co Ltd Premature Labor Treatment Product
Table 61. Kissei Pharmaceutical Co Ltd Revenue in Premature Labor Treatment Business (2017-2022) & (US$ Million)
Table 62. Kissei Pharmaceutical Co Ltd Recent Development
Table 63. Lipocine Inc Company Detail
Table 64. Lipocine Inc Business Overview
Table 65. Lipocine Inc Premature Labor Treatment Product
Table 66. Lipocine Inc Revenue in Premature Labor Treatment Business (2017-2022) & (US$ Million)
Table 67. Lipocine Inc Recent Development
Table 68. ObsEva SA Company Detail
Table 69. ObsEva SA Business Overview
Table 70. ObsEva SA Premature Labor Treatment Product
Table 71. ObsEva SA Revenue in Premature Labor Treatment Business (2017-2022) & (US$ Million)
Table 72. ObsEva SA Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Premature Labor Treatment Market Share by Type: 2021 VS 2028
Figure 2. Progesterone Features
Figure 3. OBE-022 Features
Figure 4. Retosiban Features
Figure 5. Others Features
Figure 6. Global Premature Labor Treatment Market Share by Application in 2021 & 2028
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Premature Labor Treatment Report Years Considered
Figure 11. Global Premature Labor Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Premature Labor Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Premature Labor Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Premature Labor Treatment Market Share by Players in 2021
Figure 15. Global Top Premature Labor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Labor Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Premature Labor Treatment Revenue in 2021
Figure 17. North America Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Premature Labor Treatment Market Share by Country (2017-2028)
Figure 19. United States Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Premature Labor Treatment Market Share by Country (2017-2028)
Figure 23. Germany Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Premature Labor Treatment Market Share by Region (2017-2028)
Figure 31. China Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Premature Labor Treatment Market Share by Country (2017-2028)
Figure 39. Mexico Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Premature Labor Treatment Market Share by Country (2017-2028)
Figure 43. Turkey Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Premature Labor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. AMAG Pharmaceuticals Inc Revenue Growth Rate in Premature Labor Treatment Business (2017-2022)
Figure 46. GlaxoSmithKline Plc Revenue Growth Rate in Premature Labor Treatment Business (2017-2022)
Figure 47. Juniper Pharmaceuticals Inc Revenue Growth Rate in Premature Labor Treatment Business (2017-2022)
Figure 48. Kissei Pharmaceutical Co Ltd Revenue Growth Rate in Premature Labor Treatment Business (2017-2022)
Figure 49. Lipocine Inc Revenue Growth Rate in Premature Labor Treatment Business (2017-2022)
Figure 50. ObsEva SA Revenue Growth Rate in Premature Labor Treatment Business (2017-2022)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AMAG Pharmaceuticals Inc GlaxoSmithKline Plc Juniper Pharmaceuticals Inc Kissei Pharmaceutical Co Ltd Lipocine Inc ObsEva SA